Avidity Biosciences (RNA)

• Market cap: $10.9B
• 1 day: 0.28%
• 5 days: 0.89%
• 1 month: 2.05%
• 3 months: 76.18%
• 6 months: 146.81%
• Year to date: 132.01%
• 1 year: 132.98%
• 5 years: 134.41%
• 10 years: 153.82%
• Sector: Healthcare
• Industry: Biotechnology

About: Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

Employees: 391